美纸业集团Kimberly-Clark收购印尼纸尿片生产商 扩大东南亚市占
美国纸业集团金百利克拉克(Kimberly-Clark)(KMB.US)表示,将以12亿美元现金收购纸印尼纸尿片生产商Softex Indonesia,以提升在东南亚的市占,并指收购不会对今明两年每股经调整盈利有重大影响。公司将以债务及手上现金应付收购,Softex Indonesia年销售额4.2亿美元,八成来自纸尿片,其余为女性用品及成人护理产品。
公司表示,印尼纸尿片市场为全球第六大,总值16亿美元。
金百利克拉克产品包括Huggies纸尿片、健力士(Kleenex)纸巾等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.